Timothy A Springer

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
14 Jan 25	RNAC Cartesian Therapeutics	Common Stock	Buy	Acquire P	No	No	18	4,022	72.40 k	8,531,462
13 Jan 25	RNAC Cartesian Therapeutics	Common Stock	Buy	Acquire P	No	No	17.7822	8,983	159.74 k	8,527,440
13 Jan 25	RNAC Cartesian Therapeutics	Common Stock	Buy	Acquire P	No	No	16.8576	7,962	134.22 k	8,518,457
2 Jan 25	RNAC Cartesian Therapeutics	Common Stock	Grant	Acquire A	No	No	0	2,600	0.00	8,510,495
2 Jan 25	RNAC Cartesian Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	16.93	7,800	132.05 k	7,800
23 Dec 24	RNAC Cartesian Therapeutics	Common Stock	Buy	Acquire P	No	No	18.9996	5,181	98.44 k	8,507,895
20 Dec 24	RNAC Cartesian Therapeutics	Common Stock	Buy	Acquire P	No	No	18.9435	21,800	412.97 k	8,502,714
19 Dec 24	RNAC Cartesian Therapeutics	Common Stock	Buy	Acquire P	No	No	18.928	3,376	63.90 k	8,480,914
19 Dec 24	RNAC Cartesian Therapeutics	Common Stock	Buy	Acquire P	No	No	18.3496	10,529	193.20 k	8,477,538
19 Dec 24	RNAC Cartesian Therapeutics	Common Stock	Buy	Acquire P	No	No	17.3858	11,303	196.51 k	8,467,009

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.